Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Murphy (Glasgow (Glasgow), United Kingdom), G. Jayasekera (Glasgow (Glasgow), United Kingdom), J. Mullin (Glasgow (Glasgow), United Kingdom), L. Gallagher (Glasgow (Glasgow), United Kingdom), Y. Dempsie (Glasgow (Glasgow), United Kingdom), D. Welsh (Glasgow (Glasgow), United Kingdom). Improvements in the dysfunctional right ventricle with Macitentan treatment in a sugen/hypoxic rat model of pulmonary hypertension. 1489

Member's Comments

No comment yet.

Related content which might interest you: Macitentan treatment improves the dysfunctional right ventricle in a sugen/hypoxic rat model of pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Macitentan in pulmonary hypertension due to left ventricular dysfunction Source: Eur Respir J, 51 (2) 1701886; 10.1183/13993003.01886-2017 Year: 2018 Right ventricular reserve in a piglet model of chronic pulmonary hypertension Source: Eur Respir J 2015; 45: 709-717 Year: 2015 Carvedilol partially reverses maladaptive remodeling and improves function of the right ventricle (RV) in experimentally-induced pulmonary arterial hypertension (PAH) Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009 More on the right ventricle in pulmonary hypertension Source: Eur Respir J 2015; 45: 33-35 Year: 2015 How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension Source: Eur Respir J, 50 (2) 1700764; 10.1183/13993003.00764-2017 Year: 2017 Isolated diastolic dysfunction of right ventricle: stress-induced pulmonary hypertension Source: Eur Respir J 2008; 31: 475-476 Year: 2008 The evaluation of right and left ventricular dysfunction in COPD patients with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 250s Year: 2001 The role of the right ventricle in pulmonary arterial hypertension Source: Eur Respir Rev 2011; 20: 243-253 Year: 2011 Improved right ventricular function after substantial afterload reduction in patients with pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment Year: 2012 Lodenafil improves hemodynamics and right ventricular remodeling in monocrotaline-induced model of pulmonary arterial hypertension in rats Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Pulmonary hypertension, right and left ventricular dysfunction in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 404s Year: 2006 Amelioration of right ventricular morphology and systolic function in patients with severe group 3 pulmonary hypertension treated with pulmonary vasodilators Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Cystamine and sildenafil in treatment of right ventricular hypertrophy in rats with pulmonary hypertension Source: Annual Congress 2008 - Pulmonary hypertension II Year: 2008 Upfront combination therapy reduces right ventricular volumes in pulmonary arterial hypertension Source: Eur Respir J, 49 (6) 1700007; 10.1183/13993003.00007-2017 Year: 2017 The right ventricle in pulmonary arterial hypertension Source: Eur Respir Rev 2014; 23: 476-487 Year: 2014 Echocardiographic measures of right ventricular function poorly correlate with changes in contractility and coupling in treatment naïve patients with pulmonary artery hypertension before and after therapy. Source: International Congress 2017 – Cardiac function assessment in pulmonary hypertension Year: 2017